Photoenhancer [EPC]

Photoenhancer [EPC] was reported 3889 times

Drugs of the Photoenhancer [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 POLYPOIDAL CHOROIDAL VASCULOPATHY 134 0.4323
1 CHOROIDAL HAEMATOMA 3 0.2727
2 CHOROIDAL HAEMANGIOMA 2 0.2500
3 HOLT-ORAM SYNDROME 2 0.2000
4 CHOROIDAL DYSTROPHY 6 0.1250
5 SUBRETINAL FIBROSIS 24 0.1231
6 CHOROIDAL NEOVASCULARISATION 99 0.1154
7 CHORIORETINAL DISORDER 22 0.1117
8 CHOROIDAL INFARCTION 13 0.1083
9 RETINAL PIGMENT EPITHELIAL TEAR 74 0.1066
10 CHOROIDAL RUPTURE 2 0.1053
11 EXUDATIVE RETINOPATHY 6 0.1053
12 SUBRETINAL HAEMATOMA 4 0.0889
13 MACULAR SCAR 15 0.0773
14 ANGIOGRAM ABNORMAL 8 0.0714
15 CHORIORETINAL ATROPHY 14 0.0676
16 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 58 0.0652
17 CHOROIDAL HAEMORRHAGE 12 0.0622
18 CHORIORETINAL SCAR 5 0.0602
19 AGE-RELATED MACULAR DEGENERATION 87 0.0573
20 RETINAL DEPIGMENTATION 15 0.0490
21 RETINAL SCAR 20 0.0434
22 RETINAL PIGMENT EPITHELIOPATHY 18 0.0417
23 SUBRETINAL FLUID 33 0.0302
24 RETINAL HAEMORRHAGE 214 0.0300
25 RETINAL CYST 4 0.0241
26 VITREOUS HAEMORRHAGE 63 0.0228
27 ATRIAL HYPERTROPHY 2 0.0222
28 RETINAL OEDEMA 41 0.0214
29 RETINAL ISCHAEMIA 13 0.0213
30 RETINAL EXUDATES 19 0.0203
31 RETINAL NEOVASCULARISATION 5 0.0198
32 SCOTOMA 14 0.0189
33 RETINAL DEGENERATION 24 0.0185
34 EYE OPERATION COMPLICATION 3 0.0183
35 TACHYPHYLAXIS 6 0.0172
36 FLAT ANTERIOR CHAMBER OF EYE 3 0.0168
37 MACULAR HOLE 22 0.0164
38 RETINOPATHY PROLIFERATIVE 3 0.0154
39 METAMORPHOPSIA 28 0.0152
40 CORNEAL DEFECT 2 0.0152
41 RETINAL VASCULAR DISORDER 8 0.0137
42 CHOROIDITIS 5 0.0134
43 CYSTOID MACULAR OEDEMA 25 0.0133
44 RETINAL DYSTROPHY 3 0.0126
45 VISUAL ACUITY REDUCED 403 0.0121
46 INFUSION SITE NECROSIS 2 0.0104
47 OCULAR VASCULAR DISORDER 8 0.0097
48 SEROUS RETINAL DETACHMENT 8 0.0095
49 BACTERIA URINE IDENTIFIED 2 0.0095
50 RETINAL DISORDER 23 0.0088
51 ANTERIOR CHAMBER FLARE 2 0.0086
52 SYNCOPE VASOVAGAL 7 0.0085
53 CONJUNCTIVAL DISORDER 3 0.0079
54 CAPILLARY DISORDER 3 0.0078
55 RETINAL DETACHMENT 66 0.0072
56 MACULAR OEDEMA 40 0.0071
57 CORNEAL EPITHELIUM DEFECT 4 0.0069
58 FEMORAL ARTERY OCCLUSION 2 0.0063
59 DRY AGE-RELATED MACULAR DEGENERATION 7 0.0063
60 VITREOUS DISORDER 3 0.0062
61 MACULAR FIBROSIS 4 0.0059
62 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 2 0.0058
63 HYPHAEMA 3 0.0057
64 RETINAL VASCULAR THROMBOSIS 3 0.0057
65 FAECAL OCCULT BLOOD POSITIVE 2 0.0057
66 MACULOPATHY 19 0.0054
67 RETINAL TEAR 13 0.0053
68 EYE INFECTION TOXOPLASMAL 2 0.0050
69 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 7 0.0050
70 MACULAR DEGENERATION 59 0.0049
71 CATARACT SUBCAPSULAR 3 0.0049
72 CHORIORETINOPATHY 7 0.0049
73 VITREOUS OPACITIES 4 0.0047
74 RUPTURED CEREBRAL ANEURYSM 3 0.0046
75 FIBROSIS 14 0.0045
76 CONGENITAL MUSCULOSKELETAL ANOMALY 2 0.0045
77 RETINAL VASCULAR OCCLUSION 3 0.0041
78 CORNEAL SCAR 2 0.0040
79 PRODUCT DIFFICULT TO SWALLOW 4 0.0039
80 RETINAL INJURY 3 0.0039
81 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 3 0.0035
82 EYE BURNS 2 0.0034
83 HYPERPLASIA 3 0.0033
84 INHALATION THERAPY 2 0.0032
85 NOCTURNAL DYSPNOEA 4 0.0031
86 ANOXIC ENCEPHALOPATHY 2 0.0031
87 ATROPHY 6 0.0031
88 GASTROINTESTINAL MUCOSAL DISORDER 2 0.0031
89 EXTRADURAL HAEMATOMA 4 0.0030
90 CATARACT NUCLEAR 2 0.0030
91 SEMEN VOLUME DECREASED 3 0.0030
92 TONGUE DRY 4 0.0029
93 PRODUCT COATING ISSUE 3 0.0029
94 CONGENITAL HAND MALFORMATION 2 0.0029
95 HYPOPERFUSION 3 0.0029
96 HAEMORRHAGIC CEREBRAL INFARCTION 2 0.0028
97 BURNS SECOND DEGREE 5 0.0028
98 VISUAL DISTURBANCE 16 0.0028
99 VITREOUS DETACHMENT 6 0.0028
100 HAEMORRHAGIC DISORDER 3 0.0028
101 ACCOMMODATION DISORDER 2 0.0027
102 FOREIGN BODY TRAUMA 2 0.0027
103 AMINO ACID LEVEL INCREASED 2 0.0027
104 CHROMATOPSIA 2 0.0026
105 CHEMICAL BURN 3 0.0026
106 MACROCYTOSIS 3 0.0026
107 INJECTION SITE BURNING 2 0.0026
108 CHOROIDAL EFFUSION 2 0.0025
109 INJECTION SITE NECROSIS 5 0.0025
110 HELICOBACTER GASTRITIS 3 0.0024
111 INFUSION SITE OEDEMA 2 0.0024
112 CEREBELLAR INFARCTION 4 0.0024
113 IMMUNE RECONSTITUTION SYNDROME 3 0.0023
114 CLEFT LIP 2 0.0023
115 EXTRAVASATION 9 0.0022
116 CERUMEN IMPACTION 2 0.0022
117 CULTURE URINE POSITIVE 3 0.0021
118 BLOOD LACTIC ACID INCREASED 11 0.0021
119 RETINAL VEIN OCCLUSION 6 0.0021
120 VISUAL FIELD DEFECT 15 0.0021
121 RETINAL ARTERY OCCLUSION 5 0.0020
122 CHEMICAL BURN OF SKIN 5 0.0020
123 EYE HAEMORRHAGE 26 0.0019
124 HEPATIC NEOPLASM MALIGNANT 4 0.0019
125 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
126 WRONG PATIENT RECEIVED MEDICATION 5 0.0018
127 COMPLEX PARTIAL SEIZURES 2 0.0018
128 RETINAL THICKENING 3 0.0018
129 THERAPEUTIC RESPONSE DELAYED 5 0.0018
130 PUPIL FIXED 3 0.0017
131 BREAST DISCHARGE 3 0.0017
132 PHARYNGOLARYNGEAL PAIN 9 0.0017
133 MYOPIA 4 0.0017
134 NASAL OEDEMA 3 0.0017
135 CEREBRAL ARTERY EMBOLISM 2 0.0016
136 ESSENTIAL HYPERTENSION 3 0.0016
137 CONTRAST MEDIA ALLERGY 3 0.0016
138 EJECTION FRACTION ABNORMAL 2 0.0016
139 BLOOD UREA DECREASED 2 0.0016
140 ANGLE CLOSURE GLAUCOMA 4 0.0016
141 AORTIC ARTERIOSCLEROSIS 4 0.0016
142 APPLICATION SITE EROSION 2 0.0016
143 IATROGENIC INJURY 2 0.0016
144 DACRYOSTENOSIS ACQUIRED 2 0.0015
145 CALCIUM DEFICIENCY 2 0.0015
146 CONCOMITANT DISEASE PROGRESSION 3 0.0015
147 NAIL DISCOLOURATION 6 0.0015
148 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
149 IMPLANTABLE DEFIBRILLATOR INSERTION 2 0.0015
150 FOREIGN BODY 6 0.0015
151 ANION GAP INCREASED 2 0.0015
152 CANDIDIASIS 6 0.0015
153 CYSTITIS NONINFECTIVE 2 0.0015
154 DISEASE PROGRESSION 176 0.0015
155 INTRAOCULAR PRESSURE INCREASED 19 0.0015
156 NEOPLASM RECURRENCE 5 0.0015
157 INFUSION SITE RASH 2 0.0015
158 APPLICATION SITE INFLAMMATION 2 0.0014
159 ANAEMIA MACROCYTIC 3 0.0014
160 GENITAL RASH 2 0.0014
161 APRAXIA 2 0.0013
162 CALCINOSIS 3 0.0013
163 CORNEAL OEDEMA 3 0.0013
164 READING DISORDER 3 0.0013
165 CLAVICLE FRACTURE 5 0.0013
166 INJECTION SITE EXTRAVASATION 16 0.0013
167 DRUG EFFECT INCREASED 4 0.0013
168 HISTOPLASMOSIS DISSEMINATED 2 0.0013
169 AORTIC VALVE DISEASE 2 0.0012
170 ORAL INTAKE REDUCED 3 0.0012
171 BRONCHITIS CHRONIC 3 0.0012
172 BLINDNESS UNILATERAL 17 0.0012
173 CROHN'S DISEASE 8 0.0012
174 INCORRECT STORAGE OF DRUG 2 0.0012
175 HANGOVER 4 0.0011
176 DRUG SCREEN NEGATIVE 2 0.0011
177 INFUSION SITE EXTRAVASATION 7 0.0011
178 CONJUNCTIVAL HYPERAEMIA 4 0.0011
179 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
180 PHARMACEUTICAL PRODUCT COMPLAINT 28 0.0011
181 BLOOD CHOLESTEROL DECREASED 2 0.0011
182 EJACULATION DISORDER 3 0.0011
183 COMMUNICATION DISORDER 4 0.0010
184 ADRENAL DISORDER 2 0.0010
185 CLEFT PALATE 2 0.0010
186 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
187 REBOUND ACID HYPERSECRETION 3 0.0010
188 DIVERTICULUM 7 0.0010
189 CHEST X-RAY ABNORMAL 3 0.0010
190 IRON DEFICIENCY ANAEMIA 9 0.0010
191 STOMACH DISCOMFORT 5 0.0010
192 SCAB 11 0.0010
193 ACCIDENTAL EXPOSURE 4 0.0010
194 ATRIAL TACHYCARDIA 2 0.0010
195 PHOTOPSIA 6 0.0009
196 NON-CARDIAC CHEST PAIN 3 0.0009
197 CEREBRAL INFARCTION 23 0.0009
198 SCAR 16 0.0009
199 BLINDNESS 38 0.0009
200 POLYP 6 0.0009
201 BREAST ENLARGEMENT 3 0.0009
202 TONGUE DISCOLOURATION 4 0.0009
203 PROCEDURAL COMPLICATION 7 0.0009
204 INTENTIONAL DEVICE MISUSE 4 0.0009
205 FAECES PALE 2 0.0009
206 NEPHRITIS 3 0.0009
207 DIFFICULTY IN WALKING 3 0.0009
208 HAIR GROWTH ABNORMAL 6 0.0009
209 NEPHROGENIC ANAEMIA 4 0.0009
210 CONTRAST MEDIA REACTION 2 0.0008
211 SPINAL COLUMN STENOSIS 4 0.0008
212 HEARING IMPAIRED 5 0.0008
213 EYE OEDEMA 2 0.0008
214 RECTAL DISCHARGE 3 0.0008
215 BLINDNESS TRANSIENT 6 0.0008
216 CARTILAGE INJURY 2 0.0008
217 EXPIRED DRUG ADMINISTERED 4 0.0008
218 TENDON INJURY 3 0.0008
219 SUNBURN 6 0.0008
220 INFREQUENT BOWEL MOVEMENTS 2 0.0008
221 WRONG TECHNIQUE IN DRUG USAGE PROCESS 29 0.0008
222 HYPERPARATHYROIDISM SECONDARY 2 0.0008
223 EXCORIATION 2 0.0008
224 HOSTILITY 2 0.0008
225 SKIN BURNING SENSATION 56 0.0008
226 ANOREXIA 10 0.0008
227 BLOOD CHLORIDE DECREASED 2 0.0008
228 ERUCTATION 15 0.0008
229 ACNE 58 0.0008
230 PRODUCT FORMULATION ISSUE 5 0.0008
231 GASTROINTESTINAL STROMAL TUMOUR 2 0.0008
232 ANGIONEUROTIC OEDEMA 2 0.0007
233 HYPERLACTACIDAEMIA 2 0.0007
234 PRODUCT SIZE ISSUE 4 0.0007
235 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
236 ABDOMINAL RIGIDITY 2 0.0007
237 ANORGASMIA 2 0.0007
238 ABNORMAL LOSS OF WEIGHT 5 0.0007
239 ANAPHYLACTOID REACTION 3 0.0007
240 CHOKING SENSATION 4 0.0007
241 STREPTOCOCCAL INFECTION 4 0.0007
242 NECROSIS 4 0.0007
243 FORMICATION 5 0.0007
244 APHONIA 10 0.0007
245 SELF-INJURIOUS IDEATION 3 0.0007
246 SLEEP TERROR 3 0.0007
247 INFUSION SITE ERYTHEMA 6 0.0007
248 LUNG NEOPLASM 3 0.0007
249 PURULENT DISCHARGE 3 0.0007
250 ROTATOR CUFF SYNDROME 9 0.0007
251 ABNORMAL SENSATION IN EYE 3 0.0007
252 MONOPLEGIA 3 0.0007
253 MELANOCYTIC NAEVUS 3 0.0007
254 HYPERTRIGLYCERIDAEMIA 4 0.0007
255 FEELING DRUNK 5 0.0007
256 INFUSION SITE REACTION 2 0.0007
257 BONE MARROW DISORDER 2 0.0007
258 CATARACT 39 0.0007
259 BODY HEIGHT DECREASED 7 0.0007
260 TENDON RUPTURE 8 0.0006
261 NASAL DRYNESS 4 0.0006
262 ARTERIOSCLEROSIS 6 0.0006
263 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 45 0.0006
264 PULSE ABSENT 3 0.0006
265 EYE INFLAMMATION 6 0.0006
266 FAECAL INCONTINENCE 3 0.0006
267 HERPES SIMPLEX 4 0.0006
268 ANGINA UNSTABLE 4 0.0006
269 PHOTOSENSITIVITY REACTION 10 0.0006
270 CYTOLYTIC HEPATITIS 2 0.0006
271 EYELID OEDEMA 7 0.0006
272 CAESAREAN SECTION 7 0.0006
273 HAIR TEXTURE ABNORMAL 8 0.0006
274 PERITONITIS BACTERIAL 6 0.0006
275 PAIN OF SKIN 16 0.0006
276 CORONARY ARTERIAL STENT INSERTION 3 0.0006
277 SKIN IRRITATION 27 0.0006
278 DRUG DELIVERY SYSTEM MALFUNCTION 3 0.0006
279 WEIGHT LOSS POOR 3 0.0006
280 DRUG ADMINISTRATION ERROR 18 0.0006
281 SKIN EXFOLIATION 49 0.0006
282 SKIN NECROSIS 3 0.0006
283 NOCTURIA 7 0.0006
284 POST PROCEDURAL COMPLICATION 11 0.0006
285 GLAUCOMA 11 0.0006
286 FOOD CRAVING 3 0.0006
287 INCONTINENCE 6 0.0006
288 LUNG INFILTRATION 5 0.0006
289 HEART DISEASE CONGENITAL 2 0.0006
290 THERMAL BURN 4 0.0006
291 HAEMORRHAGIC DIATHESIS 2 0.0006
292 INJECTION SITE DISCOLOURATION 7 0.0006
293 DRUG EXPOSURE DURING PREGNANCY 19 0.0006
294 CHEILITIS 3 0.0006
295 TIC 3 0.0005
296 NONSPECIFIC REACTION 3 0.0005
297 FOOD INTOLERANCE 2 0.0005
298 GASTROINTESTINAL PAIN 6 0.0005
299 CARDIOMYOPATHY 8 0.0005
300 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
301 URINARY INCONTINENCE 16 0.0005
302 NERVE INJURY 6 0.0005
303 HYPERACUSIS 2 0.0005
304 HEART RATE IRREGULAR 12 0.0005
305 MITRAL VALVE INCOMPETENCE 6 0.0005
306 IMPAIRED DRIVING ABILITY 6 0.0005
307 GRANULOCYTOPENIA 3 0.0005
308 GINGIVAL DISORDER 2 0.0005
309 HYPERVENTILATION 3 0.0005
310 LOCAL SWELLING 9 0.0005
311 THERAPEUTIC RESPONSE DECREASED 31 0.0005
312 URINE ODOUR ABNORMAL 3 0.0005
313 VITREOUS FLOATERS 5 0.0005
314 THERAPY CHANGE 5 0.0005
315 CATARACT OPERATION 3 0.0005
316 FURUNCLE 4 0.0005
317 RENAL CYST 4 0.0005
318 HYPERPHAGIA 2 0.0005
319 PRODUCT QUALITY ISSUE 68 0.0005
320 ENDOPHTHALMITIS 3 0.0005
321 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
322 MUSCULOSKELETAL PAIN 26 0.0005
323 INJECTION SITE VESICLES 3 0.0005
324 APPLICATION SITE DISCOLOURATION 2 0.0005
325 VULVOVAGINAL BURNING SENSATION 3 0.0005
326 INITIAL INSOMNIA 5 0.0005
327 EYE DISORDER 16 0.0005
328 HAIR DISORDER 4 0.0005
329 MIDDLE INSOMNIA 9 0.0005
330 SWOLLEN TONGUE 15 0.0005
331 CONGESTIVE CARDIOMYOPATHY 2 0.0005
332 CHRONIC KIDNEY DISEASE 36 0.0005
333 GASTRIC ULCER 9 0.0005
334 BUNDLE BRANCH BLOCK LEFT 2 0.0005
335 IMPAIRED WORK ABILITY 10 0.0005
336 MUSCLE STRAIN 4 0.0005
337 CHAPPED LIPS 2 0.0005
338 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
339 DIVERTICULUM INTESTINAL 2 0.0005
340 SKIN DISCOLOURATION 21 0.0005
341 GROIN PAIN 4 0.0005
342 PULMONARY CONGESTION 6 0.0005
343 WALKING AID USER 3 0.0005
344 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
345 THYROID DISORDER 7 0.0005
346 GINGIVAL SWELLING 2 0.0005
347 INFUSION RELATED REACTION 30 0.0005
348 TENDONITIS 7 0.0005
349 ILEUS PARALYTIC 2 0.0004
350 JOINT RANGE OF MOTION DECREASED 6 0.0004
351 RASH PAPULAR 10 0.0004
352 ABASIA 11 0.0004
353 AGEUSIA 11 0.0004
354 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
355 CRYING 16 0.0004
356 MYOCARDIAL ISCHAEMIA 5 0.0004
357 ABDOMINAL HERNIA 2 0.0004
358 ECCHYMOSIS 3 0.0004
359 PERIPHERAL COLDNESS 6 0.0004
360 MADAROSIS 5 0.0004
361 DEFAECATION URGENCY 3 0.0004
362 BLOOD IRON DECREASED 5 0.0004
363 DISEASE RECURRENCE 20 0.0004
364 WRIST FRACTURE 5 0.0004
365 PANIC REACTION 3 0.0004
366 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
367 TONGUE DISORDER 3 0.0004
368 PRESYNCOPE 10 0.0004
369 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
370 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
371 INFLAMMATORY BOWEL DISEASE 4 0.0004
372 DYSPEPSIA 40 0.0004
373 FLATULENCE 23 0.0004
374 DRY SKIN 54 0.0004
375 HAEMATOCRIT DECREASED 8 0.0004
376 HAIR COLOUR CHANGES 5 0.0004
377 OCULAR HYPERAEMIA 19 0.0004
378 BACK PAIN 93 0.0004
379 CORONARY ARTERY STENOSIS 2 0.0004
380 PAROSMIA 3 0.0004
381 FEELING COLD 11 0.0004
382 DRY THROAT 4 0.0004
383 DYSPHONIA 23 0.0004
384 INJECTION SITE IRRITATION 5 0.0004
385 MOTOR DYSFUNCTION 4 0.0004
386 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
387 DRUG EFFECT DECREASED 21 0.0004
388 INCREASED UPPER AIRWAY SECRETION 2 0.0004
389 PERICARDIAL EFFUSION 9 0.0004
390 CEREBRAL ISCHAEMIA 2 0.0004
391 PAIN IN JAW 11 0.0004
392 RASH GENERALISED 10 0.0004
393 DRUG EFFECT INCOMPLETE 14 0.0004
394 APNOEA 3 0.0004
395 VENTRICULAR EXTRASYSTOLES 4 0.0004
396 BONE DISORDER 7 0.0004
397 END STAGE RENAL DISEASE 7 0.0004
398 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
399 AFFECTIVE DISORDER 3 0.0004
400 VISION BLURRED 52 0.0004
401 BLOOD ALBUMIN DECREASED 3 0.0004
402 ATRIAL FLUTTER 3 0.0004
403 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
404 SENSORY LOSS 3 0.0004
405 POOR QUALITY SLEEP 8 0.0004
406 PRURITUS GENERALISED 8 0.0004
407 ERYTHEMA 76 0.0004
408 BLOOD URINE PRESENT 7 0.0004
409 PALLOR 10 0.0004
410 SLEEP APNOEA SYNDROME 7 0.0004
411 INCREASED APPETITE 7 0.0004
412 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
413 HYPERAESTHESIA 3 0.0004
414 PRODUCT SUBSTITUTION ISSUE 21 0.0004
415 MYALGIA 62 0.0004
416 CORONARY ARTERY OCCLUSION 5 0.0004
417 ASTHENOPIA 2 0.0004
418 INJECTION SITE NODULE 4 0.0004
419 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
420 DEAFNESS UNILATERAL 2 0.0004
421 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
422 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
423 ORAL DISCOMFORT 5 0.0004
424 HEART RATE ABNORMAL 2 0.0004
425 ATRIAL SEPTAL DEFECT 3 0.0004
426 THROAT IRRITATION 16 0.0004
427 ANGER 12 0.0004
428 DYSURIA 13 0.0004
429 BRONCHOSPASM 5 0.0004
430 MICTURITION URGENCY 4 0.0003
431 PRODUCT CONTAINER ISSUE 3 0.0003
432 CARDIAC VALVE DISEASE 2 0.0003
433 CONVULSION 20 0.0003
434 PREGNANCY 7 0.0003
435 SKIN HYPERPIGMENTATION 3 0.0003
436 BLOOD URIC ACID INCREASED 2 0.0003
437 NERVOUSNESS 18 0.0003
438 RASH MACULAR 12 0.0003
439 NAIL DISORDER 3 0.0003
440 FEELING HOT 21 0.0003
441 BLOOD CALCIUM INCREASED 3 0.0003
442 HEART RATE DECREASED 12 0.0003
443 SPINAL OSTEOARTHRITIS 3 0.0003
444 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
445 COLD SWEAT 6 0.0003
446 BLOOD PRESSURE INCREASED 52 0.0003
447 NECK PAIN 19 0.0003
448 ENERGY INCREASED 2 0.0003
449 PERITONITIS 7 0.0003
450 ARRHYTHMIA 16 0.0003
451 WRONG DRUG ADMINISTERED 3 0.0003
452 OEDEMA PERIPHERAL 41 0.0003
453 FACIAL PAIN 3 0.0003
454 CARDIAC PACEMAKER INSERTION 2 0.0003
455 INTENTIONAL DRUG MISUSE 7 0.0003
456 FEAR 9 0.0003
457 LIP DRY 3 0.0003
458 ECONOMIC PROBLEM 5 0.0003
459 OSTEOPENIA 5 0.0003
460 HIDRADENITIS 3 0.0003
461 ALOPECIA 64 0.0003
462 GRAND MAL CONVULSION 3 0.0003
463 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
464 MEDICATION ERROR 18 0.0003
465 HEART RATE INCREASED 32 0.0003
466 FAECES DISCOLOURED 7 0.0003
467 THINKING ABNORMAL 6 0.0003
468 LUNG INFECTION 5 0.0003
469 ERYTHEMA MULTIFORME 3 0.0003
470 EYE PAIN 18 0.0003
471 PHOTOPHOBIA 6 0.0003
472 ABORTION INDUCED 3 0.0003
473 INFUSION SITE SWELLING 2 0.0003
474 APPLICATION SITE PAIN 7 0.0003
475 FLUSHING 32 0.0003
476 DRUG DOSE OMISSION 52 0.0003
477 FOREIGN BODY SENSATION IN EYES 2 0.0003
478 CHEST DISCOMFORT 32 0.0003
479 DRUG PRESCRIBING ERROR 6 0.0003
480 LOSS OF CONSCIOUSNESS 40 0.0003
481 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
482 MOVEMENT DISORDER 10 0.0003
483 DRUG RESISTANCE 8 0.0003
484 ATELECTASIS 3 0.0003
485 CHROMATURIA 7 0.0003
486 CARDIAC FLUTTER 2 0.0003
487 INCOHERENT 2 0.0003
488 MUSCLE TIGHTNESS 5 0.0003
489 INJECTION SITE INDURATION 4 0.0003
490 DIPLOPIA 8 0.0003
491 CHOKING 6 0.0003
492 BACK DISORDER 5 0.0003
493 BRADYPHRENIA 2 0.0003
494 RENAL TUBULAR NECROSIS 3 0.0003
495 ARTHRITIS 24 0.0003
496 GASTRITIS 8 0.0003
497 RENAL INJURY 9 0.0003
498 CHEST PAIN 56 0.0003
499 BLOOD PRESSURE DECREASED 20 0.0003
500 MALIGNANT MELANOMA 4 0.0003
501 LACRIMATION INCREASED 9 0.0003
502 TOXIC SKIN ERUPTION 3 0.0003
503 CORONARY ARTERY DISEASE 9 0.0003
504 VAGINAL DISCHARGE 3 0.0003
505 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
506 SUBARACHNOID HAEMORRHAGE 3 0.0003
507 SLUGGISHNESS 3 0.0003
508 BODY TEMPERATURE INCREASED 6 0.0003
509 HYPOAESTHESIA 44 0.0003
510 TREATMENT NONCOMPLIANCE 16 0.0003
511 EAR DISCOMFORT 3 0.0003
512 SWELLING FACE 19 0.0003
513 CONTUSION 28 0.0003
514 MUSCULAR WEAKNESS 33 0.0003
515 BONE PAIN 17 0.0003
516 RESPIRATORY DISTRESS 8 0.0003
517 EYE DISCHARGE 3 0.0003
518 AUTOIMMUNE HEPATITIS 2 0.0003
519 ATRIAL FIBRILLATION 28 0.0003
520 WEIGHT FLUCTUATION 3 0.0003
521 PRODUCT ODOUR ABNORMAL 3 0.0003
522 DIZZINESS 142 0.0003
523 SKIN REACTION 4 0.0003
524 JOINT DISLOCATION 3 0.0003
525 DUODENAL ULCER 2 0.0003
526 RENAL PAIN 3 0.0003
527 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
528 HAND FRACTURE 2 0.0003
529 RETCHING 6 0.0003
530 BREAST PAIN 3 0.0003
531 THIRST 5 0.0003
532 RED BLOOD CELL COUNT DECREASED 8 0.0003
533 GOUT 5 0.0003
534 PARAESTHESIA ORAL 4 0.0003
535 MENSTRUATION DELAYED 3 0.0003
536 RASH PRURITIC 15 0.0003
537 AMNESIA 18 0.0003
538 DERMATITIS BULLOUS 2 0.0003
539 BLOOD GLUCOSE FLUCTUATION 3 0.0003
540 JOINT SWELLING 33 0.0003
541 CEREBRAL DISORDER 2 0.0003
542 ASTHENIA 101 0.0003
543 SPEECH DISORDER 14 0.0003
544 FEELING ABNORMAL 64 0.0003
545 MUSCLE SPASMS 49 0.0003
546 PARAESTHESIA 42 0.0003
547 JOINT STIFFNESS 7 0.0003
548 GAIT DISTURBANCE 51 0.0003
549 HEPATIC CIRRHOSIS 5 0.0003
550 BREAST TENDERNESS 2 0.0003
551 HYPOAESTHESIA ORAL 4 0.0003
552 FOOT FRACTURE 5 0.0003
553 FEELING JITTERY 5 0.0003
554 TINNITUS 12 0.0003
555 NEOPLASM 3 0.0003
556 DRY EYE 13 0.0003
557 CONDITION AGGRAVATED 79 0.0003
558 ATRIOVENTRICULAR BLOCK 2 0.0003
559 LIMB DISCOMFORT 8 0.0003
560 MUSCULOSKELETAL CHEST PAIN 4 0.0003
561 ANKLE FRACTURE 4 0.0003
562 PAIN IN EXTREMITY 76 0.0003
563 LIMB INJURY 7 0.0003
564 EJECTION FRACTION DECREASED 4 0.0003
565 HYPERHIDROSIS 33 0.0003
566 DYSPNOEA 145 0.0003
567 RECTAL HAEMORRHAGE 11 0.0003
568 DYSGEUSIA 19 0.0003
569 HYPERSENSITIVITY 47 0.0003
570 DYSPHAGIA 24 0.0003
571 SINUS DISORDER 5 0.0003
572 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
573 INJECTION SITE HAEMORRHAGE 20 0.0003
574 BLOOD GLUCOSE DECREASED 12 0.0002
575 HIP FRACTURE 8 0.0002
576 NIGHT SWEATS 8 0.0002
577 ASPHYXIA 2 0.0002
578 ANGINA PECTORIS 7 0.0002
579 OSTEOPOROSIS 10 0.0002
580 INFLUENZA LIKE ILLNESS 20 0.0002
581 BALANCE DISORDER 21 0.0002
582 EYE SWELLING 9 0.0002
583 DEVICE MALFUNCTION 17 0.0002
584 ILEUS 3 0.0002
585 DISTURBANCE IN ATTENTION 13 0.0002
586 EXPIRED PRODUCT ADMINISTERED 8 0.0002
587 INSOMNIA 64 0.0002
588 FUNGAL INFECTION 8 0.0002
589 SYNCOPE 24 0.0002
590 PRODUCT USE ISSUE 45 0.0002
591 HAEMORRHAGE 25 0.0002
592 BLOOD UREA INCREASED 4 0.0002
593 DERMATITIS 5 0.0002
594 OROPHARYNGEAL PAIN 22 0.0002
595 MUSCLE ATROPHY 3 0.0002
596 CARDIAC FAILURE CONGESTIVE 19 0.0002
597 BLOOD CHOLESTEROL INCREASED 11 0.0002
598 OSTEOARTHRITIS 10 0.0002
599 MYOCARDIAL INFARCTION 41 0.0002
600 EATING DISORDER 5 0.0002
601 DRY MOUTH 19 0.0002
602 ERECTILE DYSFUNCTION 6 0.0002
603 DEPRESSION 53 0.0002
604 IRRITABILITY 14 0.0002
605 INFUSION SITE PAIN 3 0.0002
606 PARANOIA 4 0.0002
607 BLOOD MAGNESIUM DECREASED 2 0.0002
608 CARDIAC MURMUR 2 0.0002
609 PLATELET COUNT INCREASED 3 0.0002
610 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
611 MENTAL DISORDER 10 0.0002
612 VERTIGO 14 0.0002
613 MUSCULOSKELETAL STIFFNESS 20 0.0002
614 IMMUNE SYSTEM DISORDER 3 0.0002
615 TOOTH INFECTION 3 0.0002
616 EPISTAXIS 17 0.0002
617 MELAENA 5 0.0002
618 EMOTIONAL DISORDER 7 0.0002
619 URTICARIA 38 0.0002
620 LYMPHADENOPATHY 8 0.0002
621 EYE IRRITATION 13 0.0002
622 DRUG ERUPTION 4 0.0002
623 EAR INFECTION 6 0.0002
624 ARTHRALGIA 93 0.0002
625 QUALITY OF LIFE DECREASED 3 0.0002
626 PULMONARY OEDEMA 10 0.0002
627 SNEEZING 5 0.0002
628 THERAPY NON-RESPONDER 10 0.0002
629 PALPITATIONS 26 0.0002
630 THROAT TIGHTNESS 6 0.0002
631 TOOTHACHE 4 0.0002
632 DRUG TOXICITY 3 0.0002
633 CYSTITIS 7 0.0002
634 PANIC ATTACK 8 0.0002
635 ABDOMINAL PAIN UPPER 45 0.0002
636 SOMNOLENCE 44 0.0002
637 HEADACHE 137 0.0002
638 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
639 COUGH 61 0.0002
640 INCREASED TENDENCY TO BRUISE 2 0.0002
641 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
642 MUSCLE TWITCHING 5 0.0002
643 TREMOR 36 0.0002
644 BLOOD GLUCOSE ABNORMAL 4 0.0002
645 CARPAL TUNNEL SYNDROME 3 0.0002
646 BURNING SENSATION 15 0.0002
647 BLISTER 12 0.0002
648 SLEEP DISORDER 15 0.0002
649 OFF LABEL USE 186 0.0002
650 BLOOD SODIUM DECREASED 4 0.0002
651 WEIGHT DECREASED 59 0.0002
652 RENAL FAILURE 28 0.0002
653 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
654 NEUROPATHY PERIPHERAL 20 0.0002
655 WEIGHT INCREASED 47 0.0002
656 SKIN DISORDER 7 0.0002
657 URINARY RETENTION 7 0.0002
658 ANAEMIA 40 0.0002
659 PARALYSIS 3 0.0002
660 PRODUCTIVE COUGH 10 0.0002
661 AFFECT LABILITY 2 0.0002
662 VAGINAL HAEMORRHAGE 9 0.0002
663 ANOSMIA 3 0.0002
664 HYPERTHYROIDISM 3 0.0002
665 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
666 ABDOMINAL PAIN 48 0.0002
667 LIVER FUNCTION TEST ABNORMAL 6 0.0002
668 EAR PAIN 4 0.0002
669 UNDERDOSE 15 0.0002
670 SURGERY 12 0.0002
671 SKIN FISSURES 4 0.0002
672 HEPATOMEGALY 2 0.0002
673 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
674 PRURITUS 78 0.0002
675 NIGHTMARE 7 0.0002
676 ABNORMAL BEHAVIOUR 8 0.0002
677 CONSTIPATION 44 0.0002
678 PNEUMONIA ASPIRATION 5 0.0002
679 BLOOD POTASSIUM DECREASED 6 0.0002
680 FATIGUE 155 0.0002
681 HOT FLUSH 15 0.0002
682 APHASIA 6 0.0002
683 CELLULITIS 10 0.0002
684 ABDOMINAL PAIN LOWER 5 0.0002
685 TASTE DISORDER 4 0.0002
686 DYSKINESIA 8 0.0002
687 BONE MARROW FAILURE 4 0.0002
688 EYELID PTOSIS 2 0.0002
689 ANXIETY 56 0.0002
690 DRUG DISPENSING ERROR 3 0.0002
691 NAUSEA 155 0.0002
692 PHARYNGEAL OEDEMA 3 0.0002
693 INJECTION SITE WARMTH 4 0.0002
694 LYMPHOMA 3 0.0002
695 VISUAL IMPAIRMENT 24 0.0002
696 HYPERTENSION 41 0.0002
697 SKIN ULCER 5 0.0002
698 RASH 84 0.0002
699 ABDOMINAL DISTENSION 20 0.0002
700 BONE DENSITY DECREASED 6 0.0002
701 ROAD TRAFFIC ACCIDENT 8 0.0002
702 HEPATIC ENZYME INCREASED 13 0.0002
703 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
704 HEAD INJURY 6 0.0002
705 HALLUCINATION, VISUAL 4 0.0002
706 PNEUMOTHORAX 3 0.0002
707 RESPIRATORY TRACT CONGESTION 3 0.0002
708 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
709 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
710 SCIATICA 3 0.0002
711 HYPOTHYROIDISM 6 0.0002
712 SENSORY DISTURBANCE 3 0.0002
713 MENSTRUATION IRREGULAR 5 0.0002
714 JAUNDICE 5 0.0002
715 SKIN CANCER 4 0.0002
716 HALLUCINATION 14 0.0002
717 WHEEZING 11 0.0002
718 BLOOD BILIRUBIN INCREASED 5 0.0002
719 HAEMOGLOBIN DECREASED 19 0.0002
720 ABDOMINAL DISCOMFORT 31 0.0002
721 DEVICE LEAKAGE 8 0.0002
722 MOOD ALTERED 5 0.0002
723 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
724 MULTIPLE FRACTURES 3 0.0002
725 MANIA 3 0.0002
726 VENTRICULAR TACHYCARDIA 3 0.0002
727 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
728 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
729 BLOOD GLUCOSE INCREASED 34 0.0002
730 LIP SWELLING 6 0.0002
731 COAGULOPATHY 3 0.0002
732 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
733 ORAL PAIN 4 0.0002
734 PANCREATITIS ACUTE 4 0.0002
735 FACE OEDEMA 3 0.0002
736 BLOOD CALCIUM DECREASED 2 0.0002
737 CANDIDA INFECTION 3 0.0002
738 FALL 59 0.0002
739 HEMIPARESIS 3 0.0002
740 METRORRHAGIA 3 0.0002
741 CHOLECYSTECTOMY 2 0.0002
742 GASTRIC DISORDER 6 0.0002
743 SUICIDAL IDEATION 16 0.0002
744 NEPHROLITHIASIS 8 0.0002
745 MUSCULOSKELETAL DISCOMFORT 3 0.0002
746 HERPES ZOSTER 10 0.0002
747 RENAL DISORDER 8 0.0002
748 INTENTIONAL PRODUCT MISUSE 15 0.0002
749 CEREBROVASCULAR ACCIDENT 29 0.0002
750 SWELLING 16 0.0002
751 LUNG NEOPLASM MALIGNANT 7 0.0002
752 RHINORRHOEA 11 0.0002
753 CARDIAC ARREST 14 0.0002
754 ACUTE MYOCARDIAL INFARCTION 5 0.0002
755 HYPOTENSION 34 0.0002
756 BLOOD CREATININE INCREASED 11 0.0002
757 DRUG INEFFECTIVE 222 0.0002
758 ASTHMA 19 0.0002
759 GALLBLADDER DISORDER 3 0.0002
760 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
761 POLLAKIURIA 7 0.0002
762 CARDIO-RESPIRATORY ARREST 7 0.0002
763 HYPERLIPIDAEMIA 2 0.0002
764 RASH ERYTHEMATOUS 8 0.0002
765 DIARRHOEA 108 0.0002
766 MULTIPLE SCLEROSIS 8 0.0002
767 RESPIRATORY DISORDER 5 0.0002
768 CONFUSIONAL STATE 27 0.0002
769 MOBILITY DECREASED 12 0.0002
770 LEUKOCYTOSIS 3 0.0002
771 MENTAL IMPAIRMENT 4 0.0002
772 RESTLESS LEGS SYNDROME 3 0.0002
773 HYPOGLYCAEMIA 8 0.0002
774 BURSITIS 2 0.0002
775 ACCIDENTAL OVERDOSE 6 0.0002
776 RESTLESSNESS 6 0.0002
777 VOMITING 77 0.0002
778 LUNG DISORDER 8 0.0002
779 HAEMATOCHEZIA 9 0.0002
780 ANAPHYLACTIC REACTION 9 0.0002
781 CARDIOMEGALY 2 0.0002
782 INJECTION SITE MASS 6 0.0002
783 ARTHROPATHY 9 0.0002
784 CONJUNCTIVITIS 3 0.0002
785 FEMUR FRACTURE 5 0.0002
786 INJECTION SITE ERYTHEMA 20 0.0002
787 CYST 2 0.0002
788 HEPATIC STEATOSIS 3 0.0002
789 EXPOSURE DURING PREGNANCY 10 0.0002
790 PAIN 98 0.0002
791 PLATELET COUNT DECREASED 17 0.0002
792 FRACTURE 3 0.0002
793 FLUID RETENTION 8 0.0002
794 INJURY 11 0.0002
795 LETHARGY 9 0.0002
796 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
797 ANAPHYLACTIC SHOCK 4 0.0002
798 HAEMATOMA 4 0.0002
799 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
800 HAEMORRHOIDS 3 0.0002
801 CHILLS 18 0.0002
802 NASAL CONGESTION 9 0.0002
803 DEAFNESS 4 0.0002
804 MENORRHAGIA 3 0.0002
805 STAPHYLOCOCCAL INFECTION 5 0.0002
806 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
807 DISORIENTATION 6 0.0002
808 DYSMENORRHOEA 2 0.0002
809 ADVERSE REACTION 2 0.0002
810 VIRAL INFECTION 5 0.0002
811 INJECTION SITE PRURITUS 10 0.0001
812 THROMBOSIS 12 0.0001
813 PRODUCT PHYSICAL ISSUE 3 0.0001
814 ILL-DEFINED DISORDER 9 0.0001
815 DRUG WITHDRAWAL SYNDROME 13 0.0001
816 PLEURAL EFFUSION 9 0.0001
817 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
818 COMA 7 0.0001
819 IMPAIRED GASTRIC EMPTYING 2 0.0001
820 GINGIVAL BLEEDING 2 0.0001
821 MALAISE 64 0.0001
822 SKIN LESION 4 0.0001
823 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
824 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
825 APPLICATION SITE RASH 2 0.0001
826 PNEUMONIA 47 0.0001
827 ABNORMAL DREAMS 4 0.0001
828 TOOTH LOSS 3 0.0001
829 HUNGER 2 0.0001
830 KNEE ARTHROPLASTY 3 0.0001
831 MOUTH ULCERATION 3 0.0001
832 BLOOD TEST ABNORMAL 2 0.0001
833 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
834 RENAL FAILURE ACUTE 6 0.0001
835 JOINT INJURY 3 0.0001
836 IRRITABLE BOWEL SYNDROME 3 0.0001
837 AGGRESSION 7 0.0001
838 CEREBRAL HAEMORRHAGE 5 0.0001
839 HYPERSOMNIA 4 0.0001
840 HYPOACUSIS 6 0.0001
841 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
842 INJECTION SITE BRUISING 11 0.0001
843 INJECTION SITE HAEMATOMA 2 0.0001
844 HYPOKINESIA 2 0.0001
845 ACUTE KIDNEY INJURY 21 0.0001
846 RESPIRATORY FAILURE 10 0.0001
847 GASTROENTERITIS 2 0.0001
848 DYSSTASIA 4 0.0001
849 SINUSITIS 14 0.0001
850 AGITATION 10 0.0001
851 INCORRECT DOSE ADMINISTERED 31 0.0001
852 INFLAMMATION 7 0.0001
853 NASOPHARYNGITIS 25 0.0001
854 STEVENS-JOHNSON SYNDROME 3 0.0001
855 TRANSAMINASES INCREASED 3 0.0001
856 TOOTH DISORDER 3 0.0001
857 INJECTION SITE PAIN 41 0.0001
858 DECREASED APPETITE 31 0.0001
859 DEPRESSED MOOD 7 0.0001
860 DISCOMFORT 8 0.0001
861 HIP ARTHROPLASTY 2 0.0001
862 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
863 OEDEMA 7 0.0001
864 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
865 BASAL CELL CARCINOMA 2 0.0001
866 DEHYDRATION 17 0.0001
867 PULMONARY EMBOLISM 12 0.0001
868 BLOOD PRESSURE FLUCTUATION 3 0.0001
869 ABORTION SPONTANEOUS 5 0.0001
870 LOCALISED INFECTION 3 0.0001
871 FIBROMYALGIA 3 0.0001
872 PERIPHERAL SWELLING 19 0.0001
873 BLOOD POTASSIUM INCREASED 2 0.0001
874 CHOLELITHIASIS 4 0.0001
875 IMPAIRED HEALING 4 0.0001
876 DRUG LEVEL INCREASED 2 0.0001
877 OVERDOSE 26 0.0001
878 LEUKOPENIA 6 0.0001
879 DRUG INTERACTION 19 0.0001
880 ADVERSE EVENT 11 0.0001
881 WITHDRAWAL SYNDROME 5 0.0001
882 RENAL IMPAIRMENT 10 0.0001
883 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
884 CIRCULATORY COLLAPSE 2 0.0001
885 HYPOPHAGIA 3 0.0001
886 THERAPY CESSATION 6 0.0001
887 HAEMATURIA 4 0.0001
888 UNRESPONSIVE TO STIMULI 3 0.0001
889 MIGRAINE 11 0.0001
890 ECZEMA 6 0.0001
891 APPLICATION SITE ERYTHEMA 3 0.0001
892 ANHEDONIA 3 0.0001
893 HYPOXIA 4 0.0001
894 ANGIOEDEMA 5 0.0001
895 HEAD DISCOMFORT 2 0.0001
896 PYREXIA 39 0.0001
897 FREQUENT BOWEL MOVEMENTS 3 0.0001
898 GASTROENTERITIS VIRAL 2 0.0001
899 HYPERGLYCAEMIA 4 0.0001
900 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
901 DIVERTICULITIS 3 0.0001
902 PANCYTOPENIA 6 0.0001
903 WOUND 3 0.0001
904 COGNITIVE DISORDER 5 0.0001
905 OXYGEN SATURATION DECREASED 6 0.0001
906 DYSARTHRIA 4 0.0001
907 INTESTINAL OBSTRUCTION 4 0.0001
908 URINARY TRACT INFECTION 18 0.0001
909 COLITIS 4 0.0001
910 INJECTION SITE SWELLING 8 0.0001
911 DRUG INTOLERANCE 10 0.0001
912 DYSTONIA 2 0.0001
913 INJECTION SITE REACTION 7 0.0001
914 LABORATORY TEST ABNORMAL 3 0.0001
915 PSYCHOTIC DISORDER 3 0.0001
916 DISABILITY 2 0.0001
917 ADVERSE DRUG REACTION 9 0.0001
918 PREMATURE BABY 3 0.0001
919 HEPATIC FAILURE 3 0.0001
920 STOMATITIS 6 0.0001
921 GYNAECOMASTIA 3 0.0001
922 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
923 PANCREATITIS 5 0.0001
924 MOOD SWINGS 3 0.0001
925 NO ADVERSE EVENT 17 0.0001
926 UNEVALUABLE EVENT 7 0.0001
927 DEEP VEIN THROMBOSIS 6 0.0001
928 PRODUCT DOSE OMISSION 6 0.0001
929 LIVER DISORDER 4 0.0001
930 TACHYCARDIA 8 0.0001
931 INFLUENZA 10 0.0001
932 GLOSSODYNIA 2 0.0001
933 GASTROINTESTINAL DISORDER 8 0.0001
934 NEUTROPENIA 12 0.0001
935 APPLICATION SITE PRURITUS 2 0.0001
936 RHEUMATOID ARTHRITIS 10 0.0001
937 HYPERKALAEMIA 3 0.0001
938 PSORIASIS 11 0.0001
939 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
940 C-REACTIVE PROTEIN INCREASED 3 0.0001
941 ENCEPHALOPATHY 2 0.0001
942 THROMBOCYTOPENIA 9 0.0001
943 MEMORY IMPAIRMENT 11 0.0001
944 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
945 DYSPNOEA EXERTIONAL 3 0.0001
946 HAEMATEMESIS 2 0.0001
947 DIABETES MELLITUS 6 0.0001
948 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
949 HEPATITIS 2 0.0001
950 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
951 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
952 BRADYCARDIA 4 0.0001
953 BREAST CANCER 7 0.0001
954 CARDIAC DISORDER 7 0.0001
955 EMOTIONAL DISTRESS 9 0.0001
956 RHABDOMYOLYSIS 3 0.0001
957 HAEMOPTYSIS 2 0.0001
958 DEMENTIA 2 0.0001
959 DEVICE DISLOCATION 3 0.0001
960 SEPTIC SHOCK 3 0.0001
961 ASCITES 2 0.0001
962 BRONCHITIS 5 0.0001
963 DEVICE ISSUE 6 0.0001
964 HYPOKALAEMIA 3 0.0001
965 NEOPLASM MALIGNANT 4 0.0001
966 GAIT INABILITY 2 0.0001
967 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
968 HOSPITALISATION 9 0.0001
969 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
970 SEPSIS 6 0.0001
971 HEPATIC FUNCTION ABNORMAL 2 0.0001
972 HYPONATRAEMIA 3 0.0001
973 SEIZURE 6 0.0001
974 BLADDER CANCER 3 0.0001
975 CARDIAC FAILURE 4 0.0000
976 SUICIDE ATTEMPT 3 0.0000
977 FEBRILE NEUTROPENIA 3 0.0000
978 COLITIS ULCERATIVE 2 0.0000
979 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
981 DEATH 33 0.0000
982 PROSTATE CANCER 3 0.0000
983 COMPLETED SUICIDE 3 0.0000
984 INFECTION 5 0.0000
985 DEVICE EXPULSION 2 0.0000
986 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
987 TOXICITY TO VARIOUS AGENTS 4 0.0000
988 DRUG DEPENDENCE 3 0.0000
989 PRODUCT DOSE OMISSION ISSUE 4 0.0000
990 COVID-19 2 0.0000